Avidity Biosciences, Inc.（RNA）内部人交易：高管与董事近期交易
过去 18 个月，共有 21 位内部人为 Avidity Biosciences, Inc.（RNA）报告了 119 笔 Form 4 交易（最近一笔 2026-09-22）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-22 | Hughes Steven George | Chief Medical Officer | 卖出 | 21,459 | $192,058 |
| 2026-09-22 | Kenney Stephanie | Chief Corporate Affairs Officer | 卖出 | 2,375 | $21,256 |
| 2026-09-22 | Flanagan W. Michael | 董事 | 卖出 | 22,812 | $204,167 |
| 2026-09-22 | Gallagher Kathleen P. | Chief Executive Officer and President | 卖出 | 11,632 | $104,106 |
| 2026-09-22 | Boyce Sarah | 董事 | 卖出 | 126,418 | $1.1M |
| 2026-09-22 | Winslow Brendan R. | Chief Financial Officer | 卖出 | 6,742 | $60,341 |
| 2026-09-22 | Hoyos Rocio Martin | Chief Strategy Officer | 卖出 | 8,320 | $74,464 |
| 2026-09-22 | Younis Husam | Chief Scientific Officer | 卖出 | 11,216 | $100,383 |
| 2026-04-22 | Gallagher Kathleen P. | Chief Executive Officer and President | 买入 | 102,500 | $0 |
| 2026-04-22 | Younis Husam | Chief Scientific Officer | 买入 | 30,000 | $0 |
| 2026-04-22 | Hoyos Rocio Martin | Chief Strategy Officer | 买入 | 30,000 | $0 |
| 2026-04-22 | Kenney Stephanie | Chief Corporate Affairs Officer | 买入 | 30,000 | $0 |
| 2026-04-22 | Hughes Steven George | Chief Medical Officer | 买入 | 30,000 | $0 |
| 2026-04-22 | Winslow Brendan R. | Chief Financial Officer | 买入 | 30,000 | $0 |
| 2026-01-23 | Boyce Sarah | President and CEO | 卖出 | 7,993 | $579,093 |
| 2026-01-23 | MacLean Michael F | Chief Financial Officer | 卖出 | 1,807 | $130,917 |
| 2026-01-23 | MacLean Michael F | Chief Financial Officer | 卖出 | 2,735 | $198,151 |
| 2026-01-23 | LEVIN ARTHUR A | 董事 | 卖出 | 1,758 | $127,367 |
| 2026-01-23 | McCarthy Teresa | Chief Human Resources Officer | 卖出 | 1,476 | $106,936 |
| 2026-01-23 | McCarthy Teresa | Chief Human Resources Officer | 卖出 | 1,453 | $105,270 |
| 2026-01-23 | Flanagan W. Michael | Chief Scientific Officer | 卖出 | 2,558 | $185,327 |
| 2026-01-23 | Hughes Steven George | Chief Medical Officer | 卖出 | 2,017 | $146,132 |
| 2026-01-23 | Hughes Steven George | Chief Medical Officer | 卖出 | 2,878 | $208,511 |
| 2026-01-23 | Boyce Sarah | President and CEO | 卖出 | 6,394 | $463,245 |
| 2026-01-23 | Flanagan W. Michael | Chief Scientific Officer | 卖出 | 3,976 | $288,061 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22